Growth Metrics

Surgery Partners (SGRY) Gains from Investment Securities (2016 - 2025)

Surgery Partners (SGRY) has disclosed Gains from Investment Securities for 11 consecutive years, with -$100000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 99.48% to -$100000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.3 million through Dec 2025, up 565.0% year-over-year, with the annual reading at $13.3 million for FY2025, 565.0% up from the prior year.
  • Gains from Investment Securities hit -$100000.0 in Q4 2025 for Surgery Partners, up from -$5.9 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $44.3 million in Q2 2023 to a low of -$45.7 million in Q3 2023.
  • Historically, Gains from Investment Securities has averaged $1.6 million across 5 years, with a median of $250000.0 in 2021.
  • Biggest YoY gain for Gains from Investment Securities was 8960.0% in 2023; the steepest drop was 45800.0% in 2023.
  • Year by year, Gains from Investment Securities stood at -$400000.0 in 2021, then surged by 2850.0% to $11.0 million in 2022, then crashed by 104.55% to -$500000.0 in 2023, then plummeted by 3760.0% to -$19.3 million in 2024, then skyrocketed by 99.48% to -$100000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for SGRY at -$100000.0 in Q4 2025, -$5.9 million in Q3 2025, and $8.6 million in Q2 2025.